Helicobacter Infections

"Helicobacter Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.

Descriptor ID	D016481
MeSH Number(s)	C01.252.400.466
Concept/Terms	Helicobacter Infections Helicobacter Infections Infections, Helicobacter Helicobacter Infection Infection, Helicobacter

Below are MeSH descriptors whose meaning is more general than "Helicobacter Infections".

Diseases [C]
Bacterial Infections and Mycoses [C01]
Bacterial Infections [C01.252]
Gram-Negative Bacterial Infections [C01.252.400]
Helicobacter Infections [C01.252.400.466]

Below are MeSH descriptors whose meaning is related to "Helicobacter Infections".

Below are MeSH descriptors whose meaning is more specific than "Helicobacter Infections".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Helicobacter Infections" by people in this website by year, and whether "Helicobacter Infections" was a major or minor topic of these publications.

Bar chart showing 23 publications over 15 distinct years, with a maximum of 2 publications in 1998 and 2002 and 2003 and 2004 and 2006 and 2008 and 2010 and 2014

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	1	0	1
1998	1	1	2
1999	0	1	1
2002	1	1	2
2003	2	0	2
2004	2	0	2
2006	2	0	2
2007	1	0	1
2008	2	0	2
2010	1	1	2
2011	1	0	1
2013	0	1	1
2014	2	0	2
2020	1	0	1
2022	1	0	1

Below are the most recent publications written about "Helicobacter Infections" by people in Profiles.

Niroomand E, Kumar SR, Goldberg D, Kumar S. Impact of Medicaid Expansion on Incidence and Mortality from Gastric and Esophageal Cancer. Dig Dis Sci. 2023 04; 68(4):1178-1186.

View in: PubMed
Guarneri C, Ceccarelli M, Rinaldi L, Cacopardo B, Nunnari G, Guarneri F. Helicobacter pylori and skin disorders: a comprehensive review of the available literature. Eur Rev Med Pharmacol Sci. 2020 12; 24(23):12267-12287.

View in: PubMed
Watari J, Chen N, Amenta PS, Fukui H, Oshima T, Tomita T, Miwa H, Lim KJ, Das KM. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. World J Gastroenterol. 2014 May 14; 20(18):5461-73.

View in: PubMed
Villarreal-Calderon R, Lu?vano-Gonz?lez A, Arag?n-Flores M, Zhu H, Yuan Y, Xiang Q, Yan B, Stoll KA, Cross JV, Iczkowski KA, Mackinnon AC. Antral atrophy, intestinal metaplasia, and preneoplastic markers in Mexican children with Helicobacter pylori-positive and Helicobacter pylori-negative gastritis. Ann Diagn Pathol. 2014 Jun; 18(3):129-35.

View in: PubMed
Kim SV, Xiang WV, Kwak C, Yang Y, Lin XW, Ota M, Sarpel U, Rifkin DB, Xu R, Littman DR. GPR15-mediated homing controls immune homeostasis in the large intestine mucosa. Science. 2013 Jun 21; 340(6139):1456-9.

View in: PubMed
Asadi-Pooya AA, Dehghani SM, Petramfar P, Emami M, Mahmoodi M. Helicobacter pylori infection in patients with epilepsy. Seizure. 2012 Jan; 21(1):21-3.

View in: PubMed
Parish LC, Davidovici B, Wolf R. Controversies in dermatology, part III. Clin Dermatol. 2010 Sep-Oct; 28(5):477.

View in: PubMed
Cammarota G, Branca G, Ardito F, Sanguinetti M, Ianiro G, Cianci R, Torelli R, Masala G, Gasbarrini A, Fadda G, Landolfi R, Gasbarrini G. Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial. Clin Gastroenterol Hepatol. 2010 Sep; 8(9):817-820.e3.

View in: PubMed
Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, Johnson DA, Mahaffey KW, Quigley EM, Harrington RA, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Hlatky MA, Kaul S, Lindner JR, Moliterno DJ, Mukherjee D, Schofield RS, Rosenson RS, Stein JH, Weitz HH, Wesley DJ. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2008 Oct 28; 52(18):1502-17.

View in: PubMed
Watari J, Das KK, Amenta PS, Tanabe H, Tanaka A, Geng X, Lin JJ, Kohgo Y, Das KM. Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia. Clin Gastroenterol Hepatol. 2008 Apr; 6(4):409-17.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement